1
Study of a Single Dose of Pretomanid Added to an Optimized Background Regimen in Children With Rifampicin-Resistant Tuberculosis
Condition(s):Tuberculosis; Rifampicin Resistant TuberculosisLast Updated:February 7, 2024Recruiting
Include Studies Not Open or Pending
Condition(s):Tuberculosis; Rifampicin Resistant TuberculosisLast Updated:February 7, 2024Recruiting
Condition(s):HIV-1 InfectionLast Updated:April 24, 2023Not yet recruiting
Condition(s):Tuberculosis; HIV InfectionsLast Updated:September 21, 2023Recruiting
Condition(s):HIV-1 InfectionLast Updated:April 24, 2023Not yet recruiting
Condition(s):HIV Infections; Multi-Antiviral ResistanceLast Updated:June 22, 2023Recruiting
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.